Private Equity Firm Healthcare

3 Boomerang Capital

Greenwich, Connecticut, United States

3 Boomerang Capital is a private equity firm focused on lower middle market healthcare companies. The firm partners with entrepreneurs and management teams to drive accelerated growth and scale through organic growth and acquisitions.

Focus Areas
Healthcare outsourcing / biopharma services, Clinical Documentation Integrity (CDI) / physician advisory, Revenue cycle management / DRG assurance
Website
3boomerang.com

Tracked deals

5

5 tracked deals across 2024-2025.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Addon

3 addon · 1 growth capital · 1 recapitalization

3 Boomerang Capital Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for 3 Boomerang Capital. 1 2024 4 2025

Supporting Data

Recent Transactions

  • Buyer
    Enjoin, LLC, 3 Boomerang Capital
    Target
    Pediatric Resource Group, LLC
    Type
    Addon

    Enjoin, a 3 Boomerang Capital portfolio company, has acquired Pediatric Resource Group (PRG), a pediatric-focused clinical documentation integrity (CDI) and physician advisory firm. The add-on expands Enjoin’s DRG assurance and revenue integrity capabilities to include pediatric and neonatal APR-DRG expertise for children’s hospitals and health systems nationwide.

  • Buyer
    Pinnaql, Inc., 3 Boomerang Capital, L.P.
    Target
    Validation & Engineering Group, Inc. (VEG)
    Location
    Puerto Rico, United States
    Type
    Addon

    Pinnaql, a LSOMS/3 Boomerang Capital portfolio company, has acquired Validation & Engineering Group, Inc. (VEG), a provider of commissioning, qualification, and validation (CQV) services to the pharmaceutical and life sciences industries. The add-on expands Pinnaql’s CQV and engineering capabilities and geographic footprint as part of its broader life‑sciences compliance and quality services platform.

  • Buyer
    LSOMS Holdings, L.P., 3 Boomerang Capital, LP
    Target
    Pinnaql, Inc.
    Type
    Addon

    LSOMS Holdings, a platform backed by 3 Boomerang Capital, acquired Pinnaql, a provider of laboratory validation and global GxP compliance services. The majority investment is LSOMS's first acquisition and expands the platform's quality, regulatory, and lab validation capabilities for pharmaceutical, biotech, and medical device clients.

  • Buyer
    3 Boomerang Capital
    Target
    Bio-Response Solutions
    Industry
    Medical Devices

    3 Boomerang Capital has made a strategic growth investment in Bio-Response Solutions to provide capital and resources to accelerate the company’s expansion in regulated biomedical waste management. The investment will support scaling operations and expanding Bio-Response’s Aquamation and scientific sterilization equipment into funeral homes, veterinary clinics, and high-containment laboratory end markets.

  • Buyer
    3 Boomerang Capital
    Target
    Enjoin, LLC

    3 Boomerang Capital completed a majority growth recapitalization of Enjoin, LLC, a Clinical Documentation Integrity (CDI) and mid-revenue cycle solutions provider for hospitals and health systems. The investment will supply strategic resources and capital to expand Enjoin's tech-enabled CDI capabilities and support continued growth across healthcare provider markets.

Related Acquisition Pages

Selling a company? Get in front of buyers like 3 Boomerang Capital

Turn tracked acquisition activity into an outreach-ready buyer list.